| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/SJ.CLPT.6100457 |
| P698 | PubMed publication ID | 18202688 |
| P2093 | author name string | C T Dollery | |
| P2860 | cites work | Molecular imaging of cardiovascular disease. | Q53466788 |
| Recombinant roulette versus the apparent virtues of 'natural' cell receptor systems: receptor genotypes versus phenotypes | Q74800879 | ||
| Therapeutic doses of acetaminophen frequently cause elevated aminotransferases in healthy volunteers: is it significant? | Q80098094 | ||
| Cardiac troponin T following anthracycline chemotherapy in children and adolescents | Q80534852 | ||
| Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother | Q28258937 | ||
| Elimination mechanisms of therapeutic monoclonal antibodies | Q28297407 | ||
| Codeine intoxication associated with ultrarapid CYP2D6 metabolism | Q28300589 | ||
| Future contrast agents for molecular imaging in stroke | Q33290687 | ||
| Transaminase elevation on placebo during phase I trials: prevalence and significance | Q33670759 | ||
| A comparison of the pharmacological properties of guinea-pig and human recombinant 5-HT4 receptors | Q36052511 | ||
| Quantum dots for molecular pathology: their time has arrived | Q36471594 | ||
| Targeting the dopamine D2 receptor in schizophrenia | Q36539461 | ||
| Blood cardiac troponin in toxic myocardial injury: archetype of a translational safety biomarker | Q36607275 | ||
| Antibody engineering and modification technologies | Q36805087 | ||
| First visualization of adenosine A(2A) receptors in the human brain by positron emission tomography with [11C]TMSX. | Q45150561 | ||
| Quantum dot labeling and tracking of human leukemic, bone marrow and cord blood cells | Q46620877 | ||
| The antipsychotic sultopride is overdosed--a PET study of drug-induced receptor occupancy in comparison with sulpiride | Q46804198 | ||
| Adverse subjective experience with antipsychotics and its relationship to striatal and extrastriatal D2 receptors: a PET study in schizophrenia | Q48220070 | ||
| A feasibility study of [11C]SA4503-PET for evaluating sigmal receptor occupancy by neuroleptics: the binding of haloperidol to sigma1 and dopamine D2-like receptors | Q48353727 | ||
| Increased occupancy of dopamine receptors in human striatum during cue-elicited cocaine craving | Q48421523 | ||
| Robust experiment design for estimating myocardial beta adrenergic receptor concentration using PET. | Q51072080 | ||
| Assessment of the relationship between glucose and A1c using kinetic modeling. | Q51934113 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 220-225 | |
| P577 | publication date | 2008-02-01 | |
| P1433 | published in | Clinical Pharmacology & Therapeutics | Q1101529 |
| P1476 | title | Clinical pharmacology in the molecular era. | |
| P478 | volume | 83 |
| Q79675814 | Bioinformatic networks: molecular reticles for pinpointing pharmacological target selection |
| Q85041884 | Developing drug prototypes: pharmacology replaces safety and tolerability? |
| Q84259846 | Molecular therapeutics from knowledge to delivery |
| Q42418371 | Molecular therapy drives patient-centric health care paradigms |
| Q33651477 | Risk Assessment in Extrapolation of Pharmacokinetics from Preclinical Data to Humans |
Search more.